Introduction
Cerebrovascular structural abnormalities have frequently been reported in demented patients diagnosed to have Alzheimer's disease (AD) (Perlmutter and Chui, 1990; Claudio, 1996; Kalaria, 1996; Buée, 1997) . Capillary damage in AD brains consistently occurs in the form of capillary basement membrane thickening and collagen type IV accumulation, also known as fibrosis. These pathological alterations implicate several functional consequences: the thickening of the basement membrane can physically hinder nutrient transport to the neural tissue or the clearance of potentially toxic waste products from the brain, and may structurally affect the efficacy of important carrier systems of the blood-brain barrier. For example, a decreased density of glucose transporter sites supports the latest assumption and suggests reduced glucose availability in the affected brain regions (Harik, 1992;  Horwood and Davies, 1994; Mooradian et al., 1997) . Hence, the imposed metabolic crisis may be reflected by data indicating decreased cerebral glucose uptake and oxygen utilization in Alzheimer brains (Rapoport et al., 1991 , Fukuyama et al., 1994 Blesa et al., 1996) .
However, the observed cerebral capillary damage is not exclusive for AD. Similar ultrastructural alterations of the cerebral microvessel walls were described in aging and experimental cerebral hypoperfusion in rats (De Jong et al., 1990; De Jong et al., 1999) .
Cerebral hypoperfusion has drawn major attention in AD research, too. Regional cerebral blood flow measured by SPECT in AD patients demonstrated significant decrease in the hippocampal formation and temporal cortex, regions first and most severely affected in the disease (DeKosky et al., 1990; Eberling et al., 1992; O'Brien et al., 1992; Ohnishi et al., 1995) . Interestingly, cerebral hypoperfusion was also found to coincide with hypertension due to possible, high blood pressure-related lack of autoregulation of cerebral blood flow or atherosclerosis (Nobili et al., 1993; Nakane et al., 1995) . Supportive experimental evidence was obtained in spontaneously hypertensive rats where the observed reduced cerebral blood flow was reported to coincide with an additional tendency for poor learning skills Katsuta, 1997 ).
In the present study, we overview the structural alterations of brain capillaries in neurodegenerative diseases and hypertensive rats and attempt to establish a comparison between them in the light of cerebral hypoperfusion.
Cerebrovascular Pathology in Neurodegenerative Diseases
The condition of cerebrocortical capillaries of AD and PD patients was investigated in invading the cytoplasm of an embraced pericyte, was taken as fibrosis ( Fig. 4 .1.C). 3. membranous inclusion bodies and swollen pericytic profiles indicated pericytic degeneration ( Fig. 4.1 .D). One hundred capillaries per case were screened and the percentage of capillaries with any of the above-described abnormalities was calculated.
The data show that the percentage of microvessels with BMT and fibrosis has considerably increased in AD as well as in PD and PDd ( Fig. 4.2) . The occurrence of BMT was almost three times higher in the neurological diseases than in controls pointing to an obvious and remarkable increase of BMT ( Fig. 4.2 .A). Similar tendency was observed in fibrosis, but the individual variance prevented statistical significance ( Fig. 4.2.B) . In contrast, the percentage of capillaries with degenerating pericytes was found comparable in all groups ( Fig. 4 .2.C) suggesting no specific involvement of pericytic degeneration in the pathology of AD or PD. Thus, the capillary wall, specifically the basement membrane appears to be the major site of cerebrovascular damage in the investigated neurodegenerative disorders.
Cerebrovascular Pathology in Hypertension
The effects of hypertension were investigated on the cerebral capillaries of the frontoparietal cortex of Wistar-Kyoto (WKY, n=6) and spontaneously hypertensive stroke prone rats (SHR-SP, n=6). Blood pressure measurements were taken on the tail on every fourth week for a period of 20 weeks, starting when the animals were 40 weeks old. On the 60 th week, the rats were perfused with 2% paraformaldehyde, 0.05% glutaraldehyde and For the examination of microvessels, we followed the guidelines described above for the human samples, thus, the same three categories of capillary abnormalities were established: basement membrane thickening (BMT), fibrosis and degenerative pericytes. The percentage of capillaries with abnormal features was expressed as percentages of the total number of capillaries encountered.
The cortical capillaries of hypertensive animals suffered a considerable damage. The frequency of BMT increased with 25 % in the SHR-SP group (Fig. 4.3 .A) while the individual capillaries were endowed with more advanced forms of BMT compared to the alterations observed in the WKY group. Usually, larger segments of a particular capillary demonstrated clearly more pronounced alterations in the SHR-SP animals. Fibrosis, which was nearly absent in normotensive controls increased remarkably in the hypertensive cases ( Fig. 4.3 
.B).
At the same time, the condition of pericytes proved to be unaffected by high blood pressure ( Fig. 4.3 .C). The occurrence of capillaries with BMT or fibrosis correlated with the blood pressure values taken before perfusion ( Fig. 4.4.A and 4.4.B) , whereas, pericytic degeneration showed no such relationship ( Fig. 4.4 .C). 
Discussion
Here we have shown that neurological conditions such as AD and PD are accompanied by a progressive degeneration of cerebrocortical capillary wall ultrastructure in a similar manner. Furthermore, comparable microvessel damage was observed in the frontoparietal cortex of chronically hypertensive rats. Figure 5 demonstrates typical examples of these degenerative features.
The microanatomical capillary damage observed here and previously by others (Perlmutter and Chui, 1990; Claudio, 1996; Kalaria, 1996; Buée, 1997) coincides with alteration of additional, functional vascular factors in AD and possibly in PD. For example, clinical measurements of regional cerebral blood flow by the non-invasive SPECT method have indicated that AD is accompanied by a decreased regional cerebral blood flow in the Therefore we propose that hypoperfusion is a causal factor in the development of capillary alterations observed in the 2VO model, and possibly in AD and PD.
Reduced cerebral blood flow was also recorded in hypertensive patients by PET and the 133Xe-inhalation method (Nobili et al., 1993; Nakane et al., 1995) . In addition, parallel experiments revealed a comparable hypertension-induced cerebral hypoperfusion in spontaneously hypertensive rats Katsuta, 1997) . Our own findings in the hypertensive animals show that the cerebral capillary wall is damaged in a similar fashion to hypoperfused rats, as well as to AD/PD patients: the basement membrane is thickened and contains collagen deposits. Fibrosis gives a considerable contribution to aberrations in the hypertensive animals, which is, nonetheless, more pronounced and uniform among cases than either in experimental hypoperfusion or the here presented neurological diseases (AD or PD). At the same time, the increase in BMT appears higher in 2VO rats and AD/PD than in a hypertensive condition. We suggest that these differences results in the sense that both the 2VO animals and the SHR-SP rats performed worse than their controls in the learning paradigms. By putting the findings into a sequential order, we may speculate that cerebral hypoperfusion gives rise to cerebrocapillary damage which, in turn, is responsible for a mild decay of learning skills probably by preventing the optimal transport of sufficient nutrients to the neural tissue and subsequent neuronal dysfunction. In conclusion, we propose that cerebral hypoperfusion is a mild but persistently prevailing condition shared by neurological disorders -AD or PD -and chronic hypertension, and that the constantly low flow rate triggers pathologic malformations of the cerebral capillary walls.
This chain of degenerative events may be an underlying mechanism of mild memory deficits in chronic hypertension and PD, and probably contributes to a largely enhanced cognitive failure pre-established by numerous additional neuropathological factors in AD ( Fig. 4.6 ). 
